100 related articles for article (PubMed ID: 6645489)
1. Prostatic cancer--II. Inhibitors of rat prostatic 4-ene-3-ketosteroid 5 alpha-reductase derived from 6-methylene-4-androsten-3-ones.
Petrow V; Wang YS; Lack L; Sandberg A; Kadohama N; Kendle K
J Steroid Biochem; 1983 Oct; 19(4):1491-502. PubMed ID: 6645489
[TBL] [Abstract][Full Text] [Related]
2. Prostatic cancer. I. 6-Methylene-4-pregnen-3-ones as irreversible inhibitors of rat prostatic delta 4-3 ketosteroid 5 alpha-reductase.
Petrow V; Wang Y; Lack L; Sandberg A
Steroids; 1981 Aug; 38(2):121-40. PubMed ID: 7303026
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of 5 alpha-reductase inhibitors within MCF-7 human breast cancer cells.
MacIndoe JH; West ER; Petrow V
J Steroid Biochem; 1984 May; 20(5):1095-100. PubMed ID: 6727360
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of some steroidal 6-methylene derivatives on 5 alpha-reductase activity in human and rat prostate.
Kadohama N; Petrow V; Lack L; Sandberg AA
J Steroid Biochem; 1983 May; 18(5):551-8. PubMed ID: 6855230
[TBL] [Abstract][Full Text] [Related]
5. Prostate. III--A structural feature characteristic of the rat prostate 5 alpha-reductase active site.
Petrow V; Padilla GM; McPhail AT; Bruchovsky N; Schneider SL
J Steroid Biochem; 1989 Mar; 32(3):399-407. PubMed ID: 2704237
[TBL] [Abstract][Full Text] [Related]
6. LY207320 (6-methylene-4-pregnene-3,20-dione) inhibits testosterone biosynthesis, androgen uptake, 5 alpha-reductase, and produces prostatic regression in male rats.
Neubauer BL; Best KL; Blohm TR; Gates C; Goode RL; Hirsch KS; Laughlin ME; Petrow V; Smalstig EB; Stamm NB
Prostate; 1993; 23(3):181-99. PubMed ID: 8234065
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro effect of androstene derivatives as 5α-reductase type 1 enzyme inhibitors.
Bratoeff E; Sánchez A; Arellano Y; Heuze Y; Soriano J; Cabeza M
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1247-54. PubMed ID: 23051174
[TBL] [Abstract][Full Text] [Related]
10. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Liang T; Rasmusson GH; Brooks JR
J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostatic growth in rats by 6-methylene-4-3,20-dione.
Petrow V; Padilla GM; Kendle K; Tantawi A
J Endocrinol; 1982 Dec; 95(3):311-3. PubMed ID: 7175421
[No Abstract] [Full Text] [Related]
12. In vitro study of rat prostate 5 alpha-reductase activity and its inhibition.
Faredin I; Tóth I; Oszlánczy J; Scultéty S
Int Urol Nephrol; 1992; 24(2):145-54. PubMed ID: 1624258
[TBL] [Abstract][Full Text] [Related]
13. Steroidal antiandrogens and 5alpha-reductase inhibitors.
Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
[TBL] [Abstract][Full Text] [Related]
14. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
[TBL] [Abstract][Full Text] [Related]
15. Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptor.
Davies JH; Shearer RJ; Rowlands MG; Poon GK; Houghton J; Jarman M; Dowsett M
J Enzyme Inhib; 1992; 6(2):141-7. PubMed ID: 1284430
[TBL] [Abstract][Full Text] [Related]
16. Isolation of flavonoids from Populus nigra as delta 4-3-ketosteroid (5 alpha) reductase inhibitors.
Komoda Y
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3128-30. PubMed ID: 2632060
[TBL] [Abstract][Full Text] [Related]
17. Studies on a 5 alpha-reductase inhibitor and their therapeutic implications.
Petrow V; Lack L
Prog Clin Biol Res; 1981; 75B():283-97. PubMed ID: 7323098
[No Abstract] [Full Text] [Related]
18. Inhibition of rat liver steroid 5 alpha-reductase by 3-androstene-3-carboxylic acids: mechanism of enzyme-inhibitor interaction.
Levy MA; Brandt M; Heys JR; Holt DA; Metcalf BW
Biochemistry; 1990 Mar; 29(11):2815-24. PubMed ID: 2346747
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of testosterone 5 alpha-reductase by and antiandrogenicity of allenic 3-keto-5,10-secosteroids.
Voigt W; Castro A; Covey DF; Robinson CH
Acta Endocrinol (Copenh); 1978 Mar; 87(3):668-72. PubMed ID: 580152
[TBL] [Abstract][Full Text] [Related]
20. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
Penning TM; Burczynski ME; Jez JM; Lin HK; Ma H; Moore M; Ratnam K; Palackal N
Mol Cell Endocrinol; 2001 Jan; 171(1-2):137-49. PubMed ID: 11165022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
